1. Effect of OATP1B1 genetic polymorphism on the uptake of tamoxifen and its metabolite, endoxifen
   Chun-Mei Gao et al, 2017, Oncology Reports CrossRef
2. Rotundic acid induces Cas3‑MCF‑7 cell apoptosis through the p53 pathway
   Min‑Lun Nan et al, 2018, Oncology Letters CrossRef
3. Psoralidin inhibits proliferation and enhances apoptosis of human esophageal carcinoma cells via NF-κB and PI3K/Akt signaling pathways
   Zhiliang Jin et al, 2016, Oncology Letters CrossRef
4. Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways
   Zhenhua Yang et al, 2017, Oncology Reports CrossRef
5. Rotundic acid enhances the impact of radiological toxicity on MCF-7 cells through the ATM/p53 pathway
   Zhong-Feng Wang et al, 2018, International Journal of Oncology CrossRef
6. A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study
   Sara Gagno et al, 2019, Clinical Breast Cancer CrossRef
7. The role of OATP1B1 and OATP1B3 transporter polymorphisms in drug disposition and response to anticancer drugs: a review of the recent literature
   Nadeen Anabtawi et al, 2022, Expert Opinion on Drug Metabolism & Toxicology CrossRef
8. Differential effect of psoralidin in enhancing apoptosis of colon cancer cells via nuclear factor-κB and B-cell lymphoma-2/B-cell lymphoma-2-associated X protein signaling pathways
   ZHILIANG JIN et al, 2016, Oncology Letters CrossRef
9. Licochalcone A inhibits PI3K/Akt/mTOR signaling pathway activation and promotes autophagy in breast cancer cells
   Lei Xue et al, 2017, Oncology Letters CrossRef
10. Influx transporter variants as predictors of cancer chemotherapy-induced toxicity: systematic review and meta-analysis
    Zoulikha M Zaïr et al, 2016, Pharmacogenomics CrossRef
11. Effects of the SLCO1B1 A388G single nucleotide polymorphism on the development, clinical parameters, treatment, and survival of multiple myeloma cases in a Polish population
    Katarzyna Michalska et al, 2023, Molecular Biology Reports CrossRef
12. Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics
    Ondřej Slanař et al, 2021, Expert Opinion on Drug Metabolism & Toxicology CrossRef
13. Methyl jasmonate induces the apoptosis of human colorectal cancer cells via downregulation of EZH2 expression by microRNA-101
    Zheng Peng et al, 2017, Molecular Medicine Reports CrossRef
14. Pharmacogenetics of Drugs Used in the Treatment of Cancers
    Beata Franczyk et al, 2022, Genes CrossRef
15. Anticancer effects of liriodenine on the cell growth and apoptosis of human breast cancer MCF-7 cells through the upregulation of p53 expression
    Zhi-Hua Li et al, 2017, Oncology Letters CrossRef
16. Function of microRNA‑141 in human breast cancer through cytotoxic CD4+ T cells regulated by MAP4K4 expression
    Qing Zhang et al, 2018, Molecular Medicine Reports CrossRef
17. Anticancer effect of HOTTIP regulates human pancreatic cancer via the metabotropic glutamate receptor 1 pathway
    Yibiao Ye et al, 2018, Oncology Letters CrossRef